Pseudomonas aeruginosa is a significant opportunistic pathogen causing healthcare-associated infections (HAI)worldwide, its ability to form biofilms contributes to antibiotic resistance, resulting in the increased difficulty for treatment, thus finding a new therapeutic approach is crucial.
In order to address the needs of infants with cow's milk allergy, two formulations of a semi-solid, dairy-free, ready-to-use complementary food were developed. These formulations were created in an attempt to fulfill BPOM regulations and infant recommended dietary allowance values, differing only in their peanut oil to palm rations: formula 1 (30:177) and formula 2 (50:157). Both Formulae were …